These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38378893)

  • 1. PFKFB3 facilitates cell proliferation and migration in anaplastic thyroid carcinoma via the WNT/β-catenin signaling pathway.
    Deng J; Cheng Y; Li H; He X; Yu S; Ma J; Li X; Chen J; Xiao H; Guan H; Li Y
    Endocrine; 2024 Aug; 85(2):737-750. PubMed ID: 38378893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ellagic acid inhibits cell proliferation, migration, and invasion of anaplastic thyroid cancer cells via the Wnt/β-catenin and PI3K/Akt pathways.
    Meng X; Cui Z; Shi H; Ma X; Li W; Liu X; Jiang Y
    Acta Biochim Pol; 2023 Feb; 70(1):109-115. PubMed ID: 36773307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HOXD9/miR-451a/PSMB8 axis is implicated in the regulation of cell proliferation and metastasis via PI3K/AKT signaling pathway in human anaplastic thyroid carcinoma.
    Zhong Y; Yu F; Yang L; Wang Y; Liu L; Jia C; Cai H; Yang J; Sheng S; Lv Z; Weng L; Wu B; Zhang X
    J Transl Med; 2023 Nov; 21(1):817. PubMed ID: 37974228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The EPRS-ATF4-COLI pathway axis is a potential target for anaplastic thyroid carcinoma therapy.
    Mi L; Liu J; Zhang Y; Su A; Tang M; Xing Z; He T; Wei T; Li Z; Wu W
    Phytomedicine; 2024 Jul; 129():155670. PubMed ID: 38704915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CTHRC1 promotes anaplastic thyroid cancer progression by upregulating the proliferation, migration, and invasion of tumor cells.
    Chen Y; Jia L; Zhao K; Chen Z; Han Y; He X
    PeerJ; 2023; 11():e15458. PubMed ID: 37273536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcript-level regulation of MALAT1-mediated cell cycle and apoptosis genes using dual MEK/Aurora kinase inhibitor "BI-847325" on anaplastic thyroid carcinoma.
    Samimi H; Haghpanah V; Irani S; Arefian E; Sohi AN; Fallah P; Soleimani M
    Daru; 2019 Jun; 27(1):1-7. PubMed ID: 31077090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of MADD expression inhibits cellular growth and metastasis in anaplastic thyroid cancer.
    Saini S; Sripada L; Tulla K; Kumar P; Yue F; Kunda N; Maker AV; Prabhakar BS
    Cell Death Dis; 2019 Feb; 10(2):145. PubMed ID: 30760700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apatinib Inhibits Angiogenesis Via Suppressing Akt/GSK3β/ANG Signaling Pathway in Anaplastic Thyroid Cancer.
    Jin Z; Cheng X; Feng H; Kuang J; Yang W; Peng C; Shen B; Qiu W
    Cell Physiol Biochem; 2017; 44(4):1471-1484. PubMed ID: 29190616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alantolactone induces concurrent apoptosis and GSDME-dependent pyroptosis of anaplastic thyroid cancer through ROS mitochondria-dependent caspase pathway.
    Hu Y; Wen Q; Cai Y; Liu Y; Ma W; Li Q; Song F; Guo Y; Zhu L; Ge J; Zeng Q; Wang J; Yin C; Zheng G; Ge M
    Phytomedicine; 2023 Jan; 108():154528. PubMed ID: 36343549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KLF9 (Kruppel Like Factor 9) induced PFKFB3 (6-Phosphofructo-2-Kinase/Fructose-2, 6-Biphosphatase 3) downregulation inhibits the proliferation, metastasis and aerobic glycolysis of cutaneous squamous cell carcinoma cells.
    Xing J; Jia Z; Xu Y; Chen M; Yang Z; Chen Y; Han Y
    Bioengineered; 2021 Dec; 12(1):7563-7576. PubMed ID: 34612136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway.
    Zheng Y; Jiang L; Hu Y; Xiao C; Xu N; Zhou J; Zhou X
    BMC Cancer; 2017 Feb; 17(1):161. PubMed ID: 28241806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating wnt/β-catenin signaling pathway.
    Ding S; Qu W; Jiao Y; Zhang J; Zhang C; Dang S
    Cancer Biomark; 2018; 22(2):217-226. PubMed ID: 29630517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KLF5 influences cell biological function and chemotherapy sensitivity through the JNK signaling pathway in anaplastic thyroid carcinoma.
    Wang Z; Qiu X; Zhang H; Li W
    J Biochem Mol Toxicol; 2020 May; 34(5):e22469. PubMed ID: 32173973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PFKFB3 is involved in breast cancer proliferation, migration, invasion and angiogenesis.
    Peng F; Li Q; Sun JY; Luo Y; Chen M; Bao Y
    Int J Oncol; 2018 Mar; 52(3):945-954. PubMed ID: 29393396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SRY‑related HMG box‑2 role in anaplastic thyroid cancer aggressiveness is related to the fibronectin 1 and PI3K/AKT pathway.
    Wang P; Shang J; Zhao J; Wang K; Guo L; Gu J; Wang W
    Mol Med Rep; 2020 Mar; 21(3):1201-1207. PubMed ID: 31922212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Potential Oncogenic Role for PFKFB3 Overexpression in Gastric Cancer Progression.
    Lei L; Hong LL; Ling ZN; Zhong Y; Hu XY; Li P; Ling ZQ
    Clin Transl Gastroenterol; 2021 Jul; 12(7):e00377. PubMed ID: 34193800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA NEAT1 enhances the resistance of anaplastic thyroid carcinoma cells to cisplatin by sponging miR‑9‑5p and regulating SPAG9 expression.
    Yan P; Su Z; Zhang Z; Gao T
    Int J Oncol; 2019 Nov; 55(5):988-1002. PubMed ID: 31485599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo.
    Ferrari SM; Bocci G; Di Desidero T; Elia G; Ruffilli I; Ragusa F; Orlandi P; Paparo SR; Patrizio A; Piaggi S; La Motta C; Ulisse S; Baldini E; Materazzi G; Miccoli P; Antonelli A; Fallahi P
    Oncol Rep; 2018 May; 39(5):2225-2234. PubMed ID: 29517103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted inhibition of long non-coding RNA H19 blocks anaplastic thyroid carcinoma growth and metastasis.
    Zhang H; Yu Y; Zhang K; Liu X; Dai Y; Jiao X
    Bioengineered; 2019 Dec; 10(1):306-315. PubMed ID: 31299871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SOX18 exerts tumor-suppressive functions in papillary thyroid carcinoma through inhibition of Wnt/β-catenin signaling.
    Geng Q; Deng H; Fu J; Cui F
    Exp Cell Res; 2020 Nov; 396(1):112249. PubMed ID: 32858034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.